CollPlant Biotechnologies Begins Preclinical Trial with Commercial-Size, Regenerative Breast Implants
The current market for breast implants is estimated at $2.6 billion a yearCollPlant expects the study to conclude by the first half of 2024CollPlant plans to use findings from this study and...